High rate of non-albicans candidemia in Brazilian tertiary care hospitals
- PMID: 10459478
- DOI: 10.1016/s0732-8893(99)00042-5
High rate of non-albicans candidemia in Brazilian tertiary care hospitals
Abstract
In order to evaluate the epidemiology of candidemia in Brazil, we performed a prospective multicenter study conducted in six general hospitals from São Paulo and Rio de Janeiro, We enrolled a total of 145 candidemic patients (85 males) with a median age of 32 years. Non-albicans species accounted for 63% of all episodes and the species most frequently causing candidemia were C. albicans (37%), C. parapsilosis (25%), C. tropicalis (24%), C. rugosa (5%), and C. glabrata (4%). Systemic azoles were used before the onset of candidemia in only six patients. There were no differences in the coexisting exposures or underlying diseases associated with the species most frequently causing candidemia. The overall crude mortality rate was 50%. Nosocomial candidemias in our tertiary hospitals are caused predominantly by non-albicans species, which are rarely fluconazole resistant. This predominance of non-albicans species could not be related to the previous use of azoles.
Similar articles
-
Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.Infect Control Hosp Epidemiol. 2007 May;28(5):570-6. doi: 10.1086/513615. Epub 2007 Apr 13. Infect Control Hosp Epidemiol. 2007. PMID: 17464917
-
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039. Clin Infect Dis. 2009. PMID: 19441981
-
Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.Braz J Infect Dis. 2005 Oct;9(5):411-8. doi: 10.1590/s1413-86702005000500009. Epub 2006 Jan 6. Braz J Infect Dis. 2005. PMID: 16410893
-
Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.Braz J Infect Dis. 2000 Jun;4(3):113-8. Braz J Infect Dis. 2000. PMID: 10934493 Review.
-
Polymicrobial candidemia.Diagn Microbiol Infect Dis. 2002 Dec;44(4):353-7. doi: 10.1016/s0732-8893(02)00460-1. Diagn Microbiol Infect Dis. 2002. PMID: 12543540 Review.
Cited by
-
Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical.Braz J Infect Dis. 2013 May-Jun;17(3):283-312. doi: 10.1016/j.bjid.2013.02.001. Epub 2013 May 18. Braz J Infect Dis. 2013. PMID: 23693017 Free PMC article.
-
A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia.Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1071-8. doi: 10.1007/s10096-008-0546-y. Epub 2008 Jun 12. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18548295
-
Epidemiological trends in nosocomial candidemia in intensive care.BMC Infect Dis. 2006 Feb 10;6:21. doi: 10.1186/1471-2334-6-21. BMC Infect Dis. 2006. PMID: 16472387 Free PMC article.
-
Candida sp. Infections in Patients with Diabetes Mellitus.J Clin Med. 2019 Jan 10;8(1):76. doi: 10.3390/jcm8010076. J Clin Med. 2019. PMID: 30634716 Free PMC article. Review.
-
Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):470-4. doi: 10.1007/s10096-003-0973-8. Epub 2003 Jul 23. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12884068 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical